List of Synta Pharmaceuticals patents

Patents where

Current Assignee

Name

Synta Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7067514 Pyrimidine compounds	Patent 7067514 was granted and assigned to Synta Pharmaceuticals on June, 2006 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	7067514	June 27, 2006
‌ US Patent 7045517 Triazine compounds	Patent 7045517 was granted and assigned to Synta Pharmaceuticals on May, 2006 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	7045517	May 16, 2006
‌ US Patent 8053456 Triazole compounds that modulate Hsp90 activity	Patent 8053456 was granted and assigned to Synta Pharmaceuticals on November, 2011 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	8053456	November 8, 2011
‌ US Patent 11497733 Combination therapy of HSP90 inhibitors and PD-1 inhibitors for treating cancer	Patent 11497733 was granted and assigned to Synta Pharmaceuticals on November, 2022 by the United States Patent and Trademark Office.	Synta Pharmaceuticals	Synta Pharmaceuticals	United States Patent and Trademark Office	11497733	November 15, 2022
‌ US Patent 8183384 Triazole compounds that modulate HSP90 activity	Patent 8183384 was granted and assigned to Synta Pharmaceuticals on May, 2012 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	8183384	May 22, 2012
‌ US Patent 6958332 Pyrimidine compounds	Patent 6958332 was granted and assigned to Synta Pharmaceuticals on October, 2005 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	6958332	October 25, 2005
‌ US Patent 8450500 Pyrrole compounds that modulate HSP90 activity	Patent 8450500 was granted and assigned to Synta Pharmaceuticals on May, 2013 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	8450500	May 28, 2013
‌ US Patent 8106083 Triazole compounds that modulate HSP90 activity	Patent 8106083 was granted and assigned to Synta Pharmaceuticals on January, 2012 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	8106083	January 31, 2012
‌ US Patent 8415377 Triazole compounds that modulate HSP90 activity	Patent 8415377 was granted and assigned to Synta Pharmaceuticals on April, 2013 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	8415377	April 9, 2013
‌ US Patent 7615552 Fused heterocyclic compounds	Patent 7615552 was granted and assigned to Synta Pharmaceuticals on November, 2009 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	7615552	November 10, 2009
‌ US Patent 8927548 Triazole compounds that modulate HSP90 activity	Patent 8927548 was granted and assigned to Synta Pharmaceuticals on January, 2015 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	8927548	January 6, 2015
‌ US Patent 8318790 Triazole compounds that modulate HSP90 activity	Patent 8318790 was granted and assigned to Synta Pharmaceuticals on November, 2012 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	8318790	November 27, 2012
‌ US Patent 7608635 Pyrazole compounds that modulate HSP90 activity	Patent 7608635 was granted and assigned to Synta Pharmaceuticals on October, 2009 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	7608635	October 27, 2009
‌ US Patent 7919487 Heteroaryl compounds	Patent 7919487 was granted and assigned to Synta Pharmaceuticals on April, 2011 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	7919487	April 5, 2011
‌ US Patent 7709518 Compounds for inflammation and immune-related uses	Patent 7709518 was granted and assigned to Synta Pharmaceuticals on May, 2010 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	7709518	May 4, 2010
‌ US Patent 9604978 Compounds for inflammation and immune-related uses	Patent 9604978 was granted and assigned to Synta Pharmaceuticals on March, 2017 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	9604978	March 28, 2017
‌ US Patent 9006277 Triazole compounds that modulate HSP90 activity	Patent 9006277 was granted and assigned to Synta Pharmaceuticals on April, 2015 by the United States Patent and Trademark Office.	Synta Pharmaceuticals	Synta Pharmaceuticals	United States Patent and Trademark Office	9006277	April 14, 2015
‌ US Patent 7825148 Triazole compounds that modulate Hsp90 activity	Patent 7825148 was granted and assigned to Synta Pharmaceuticals on November, 2010 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	7825148	November 2, 2010
‌ US Patent 7884094 Compounds for the treatment of proliferative disorders	Patent 7884094 was granted and assigned to Synta Pharmaceuticals on February, 2011 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	7884094	February 8, 2011
‌ US Patent 8648104 Method for treating proliferative disorders associated with mutations in c-Met	Patent 8648104 was granted and assigned to Synta Pharmaceuticals on February, 2014 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	8648104	February 11, 2014
‌ US Patent 8362055 Triazole compounds that modulate HSP90 activity	Patent 8362055 was granted and assigned to Synta Pharmaceuticals on January, 2013 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	8362055	January 29, 2013
‌ US Patent 7863270 IL-12 modulatory compounds	Patent 7863270 was granted and assigned to Synta Pharmaceuticals on January, 2011 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	7863270	January 4, 2011
‌ US Patent 7763658 Treatment for cancers	Patent 7763658 was granted and assigned to Synta Pharmaceuticals on July, 2010 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	7763658	July 27, 2010
‌ US Patent 7435843 Synthesis of taxol enhancers	Patent 7435843 was granted and assigned to Synta Pharmaceuticals on October, 2008 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	7435843	October 14, 2008
‌ US Patent 7795313 Bis(thio-hydrazide amide) salts for treatment of cancers	Patent 7795313 was granted and assigned to Synta Pharmaceuticals on September, 2010 by the United States Patent and Trademark Office.		Synta Pharmaceuticals	United States Patent and Trademark Office	7795313	September 14, 2010

...

Results per page:

145 results

0 selected

145 results

0 selected